Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$27,000.00
Long-term risk of kidney disease in new cancer patients: A population-based cohort study
FY 2024-25
Summary
The purpose of the study is to examine the association between newly diagnosed cancer and long-term kidney-related outcomes, including new-onset chronic kidney disease (CKD), CKD progression, kidney failure, and the need for dialysis. As cancer survivorship increases due to advancements in screening and therapy, addressing chronic conditions like CKD, which significantly affects quality of life, becomes essential. Using a population-based retrospective cohort design, this study will use linked health administrative databases at ICES in Ontario. These databases include comprehensive information on demographics, healthcare encounters, and laboratory tests for nearly 15 million residents. The cohort will include adult patients (18+ years) newly diagnosed with solid tumors (breast, prostate, lung, and colorectal cancers), excluding those with prior cancer diagnoses, pre-existing kidney disease, or insufficient follow-up. The analysis stratifies outcomes by sex to account for biological and clinical differences between men and women. Kidney-related outcomes will be identified using validated definitions and classified through International Classification of Diseases (ICD-10) codes. The study will analyze cancer-related kidney outcomes, including new-onset CKD (eGFR <60 or ACR >30), CKD progression (>40%), kidney failure, and dialysis initiation, and will adjust for competing risks such as mortality. This research will provide critical insights into the long-term risks of CKD in cancer survivors, informing monitoring strategies, patient counseling, and CKD management tailored to at-risk groups. These findings will guide prevention, healthcare planning, and therapeutic interventions, ultimately improving quality of life and health outcomes for cancer survivors.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
529637
Name
Ahmed Sumaiya
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Long-term risk of kidney disease in new cancer patients: A population-based cohort study
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Chronic Kidney Disease; Epidemiology; Kidney Failure; Prevention
Abstract
The purpose of the study is to examine the association between newly diagnosed cancer and long-term kidney-related outcomes, including new-onset chronic kidney disease (CKD), CKD progression, kidney failure, and the need for dialysis. As cancer survivorship increases due to advancements in screening and therapy, addressing chronic conditions like CKD, which significantly affects quality of life, becomes essential. Using a population-based retrospective cohort design, this study will use linked health administrative databases at ICES in Ontario. These databases include comprehensive information on demographics, healthcare encounters, and laboratory tests for nearly 15 million residents. The cohort will include adult patients (18+ years) newly diagnosed with solid tumors (breast, prostate, lung, and colorectal cancers), excluding those with prior cancer diagnoses, pre-existing kidney disease, or insufficient follow-up. The analysis stratifies outcomes by sex to account for biological and clinical differences between men and women. Kidney-related outcomes will be identified using validated definitions and classified through International Classification of Diseases (ICD-10) codes. The study will analyze cancer-related kidney outcomes, including new-onset CKD (eGFR <60 or ACR >30), CKD progression (>40%), kidney failure, and dialysis initiation, and will adjust for competing risks such as mortality. This research will provide critical insights into the long-term risks of CKD in cancer survivors, informing monitoring strategies, patient counseling, and CKD management tailored to at-risk groups. These findings will guide prevention, healthcare planning, and therapeutic interventions, ultimately improving quality of life and health outcomes for cancer survivors.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ahmed, Sumaiya
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~